Explore daily insights on
Cipla faces 25 downward EPS revisions as consensus estimate is cut 7.1%
- Indian pharmaceutical giant Cipla Ltd faced a wave of earnings estimate downgrades from analysts.
- The consensus EPS estimate was cut by 7.1% to 51.22 rupees following 25 downward revisions over the last seven days.
- The negative revisions and a 9.5-fold volume spike reflect growing analyst skepticism about the company's near-term outlook.
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 3 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
CIPLA.NS current-year EPS estimate fell 7.1% (from 55.14 to 51.22 rupees) with 25 downward revisions in @yahoo.finance.eps_revisions and @yahoo.finance.eps_trend as of May 31, 2026. Volume was 9.54M on May 28 in @yahoo.finance.daily_prices.